{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"cardiomyopathy-dilated-2f","columns":[{"gene":"","key":"population-fcb3f40b5dda598889ff","label":"Cardiomyopathy, dilated, 2F","mondoId":"MONDO:0030680","onsetQualifier":null,"originColumnKey":"MONDO:0030680/OMIM:619747","originalViews":[{"key":"MONDO:0030680/OMIM:619747","label":"Cardiomyopathy, dilated, 2F","scopeLabel":"OMIM:619747","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["060a483435c00db4d4ac8ac0aef6329712bf17be7baed9795c64f8044a2a81b8","6750d86ce30a28157b15a1a7915b04d54fadc713361445f98ef8cfc4d399e465","6ae6532241731365285c749e25da76cb865725eedfc1f93ec2f36a22b3dfd967","6b038d2f7c7e8b9bf882e2414c1bded95384695379fa0f857c282f17d93ec73a","bd6166e20dba55718e319595809779c3f09050e7754ba36a6929346448d5b167","cdf52b2c18e9577f583292ea45e5afcf607b92e5e5add0ba0e09db02babcc732","d65d785c1ca2ee901c953709a7643b686a3f4f05fde659ccb20bc38b12f5ccad"],"recordQualifiers":{},"scopeLabel":"OMIM:619747","sourceIds":["OMIM:619747"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-fcb3f40b5dda598889ff"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001635","HP:0001644","HP:0033534","HP:0033755","HP:0012666","HP:0001663","HP:0004756"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":2,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":7,"sourceGroups":{"published":7}},"features":[{"hpoId":"HP:0001635","label":"Congestive heart failure","primary":true},{"hpoId":"HP:0001644","label":"Dilated cardiomyopathy","primary":true},{"hpoId":"HP:0033534","label":"Increased circulating brain natriuretic peptide concentration","primary":true},{"hpoId":"HP:0033755","label":"Increased left ventricular end-diastolic volume","primary":true},{"hpoId":"HP:0012666","label":"Severely reduced left ventricular ejection fraction","primary":true},{"hpoId":"HP:0001663","label":"Ventricular fibrillation","primary":true},{"hpoId":"HP:0004756","label":"Ventricular tachycardia","primary":true}],"ledeHtml":"A dilated cardiomyopathy that is characterized by refractory ventricular arrhythmias and severe heart failure and that has material basis in homozygous mutation in the BAG5 gene on chromosome 14q32.","mondoId":"MONDO:0030680","node":{"canonicalSlug":"cardiomyopathy-dilated-2f","comparisons":[{"documentSha256":"fea5be091aa44e7ac49464eb9cdbab52a2b4f86de5015ce00b4e3a5738491cff","key":"legacy-cardiomyopathy-dilated-2f","kind":"legacy","label":"cardiomyopathy, dilated, 2F","memberIds":["MONDO:0030680"],"mondoId":"MONDO:0030680","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cardiomyopathy-dilated-2f.fea5be091aa44e7ac49464eb9cdbab52a2b4f86de5015ce00b4e3a5738491cff.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"cardiomyopathy, dilated, 2F","paragraphs":["A dilated cardiomyopathy that is characterized by refractory ventricular arrhythmias and severe heart failure and that has material basis in homozygous mutation in the BAG5 gene on chromosome 14q32."],"scope":"exact","source":"MONDO","upstream":"DOID:0081162","url":"https://monarchinitiative.org/MONDO:0030680"},"ownColumnKeys":["population-fcb3f40b5dda598889ff"],"publication":"published","relationships":[{"kind":"parent","label":"familial isolated dilated cardiomyopathy","mondoId":"MONDO:0700335","slug":"familial-isolated-dilated-cardiomyopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/25609"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"060a483435c00db4d4ac8ac0aef6329712bf17be7baed9795c64f8044a2a81b8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619747","disease_name":"Cardiomyopathy, dilated, 2F","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001635","is_excluded":false,"label":"Congestive heart failure","onset_id":null,"reference":"PMID:35044787","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6750d86ce30a28157b15a1a7915b04d54fadc713361445f98ef8cfc4d399e465","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619747","disease_name":"Cardiomyopathy, dilated, 2F","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004756","is_excluded":false,"label":"Ventricular tachycardia","onset_id":null,"reference":"PMID:35044787","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6ae6532241731365285c749e25da76cb865725eedfc1f93ec2f36a22b3dfd967","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619747","disease_name":"Cardiomyopathy, dilated, 2F","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001663","is_excluded":false,"label":"Ventricular fibrillation","onset_id":null,"reference":"PMID:35044787","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6b038d2f7c7e8b9bf882e2414c1bded95384695379fa0f857c282f17d93ec73a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619747","disease_name":"Cardiomyopathy, dilated, 2F","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0012666","is_excluded":false,"label":"Severely reduced left ventricular ejection fraction","onset_id":null,"reference":"PMID:35044787","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"bd6166e20dba55718e319595809779c3f09050e7754ba36a6929346448d5b167","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:619747","disease_name":"Cardiomyopathy, dilated, 2F","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0033534","is_excluded":false,"label":"Increased circulating brain natriuretic peptide concentration","onset_id":null,"reference":"PMID:35044787","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cdf52b2c18e9577f583292ea45e5afcf607b92e5e5add0ba0e09db02babcc732","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619747","disease_name":"Cardiomyopathy, dilated, 2F","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001644","is_excluded":false,"label":"Dilated cardiomyopathy","onset_id":null,"reference":"PMID:35044787","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d65d785c1ca2ee901c953709a7643b686a3f4f05fde659ccb20bc38b12f5ccad","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:619747","disease_name":"Cardiomyopathy, dilated, 2F","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0033755","is_excluded":false,"label":"Increased left ventricular end-diastolic volume","onset_id":null,"reference":"PMID:35044787","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0030680\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>DOID:0081162</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A dilated cardiomyopathy that is characterized by refractory ventricular arrhythmias and severe heart failure and that has material basis in homozygous mutation in the BAG5 gene on chromosome 14q32.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0030680\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"cardiomyopathy-dilated-2f","sourceDocuments":[{"name":"MONDO: cardiomyopathy, dilated, 2F","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0030680"}],"sourceNote":"","synonyms":["cardiomyopathy, dilated, 2F","CMD2F"],"takeawayHtml":"","title":"cardiomyopathy, dilated, 2F"},"schemaVersion":1}
